The earnings call presented a mixed picture with strong revenue growth and successful acquisitions on the positive side, but also highlighted challenges such as declining prescription revenues and increased operating expenses leading to a higher net loss. The strategy to invest in growth postpones profitability but aims for long-term value creation.

Company Guidance -

Q3 2025

During the second quarter of 2025, electroCore reported record revenue of $7.4 million, marking a 20% increase year-over-year and a 10% sequential rise. The company achieved a strong gross margin of 87%, up from 86% the previous year. The VA hospital system remained a significant contributor, with revenue growing 12% sequentially, from $4.7 million in Q1 to $5.3 million in Q2. ElectroCore's U.S. prescription channel generated $394,000 in revenue, although it experienced a 17% decline year-over-year. Meanwhile, the Truvaga brand achieved $1 million in Q2 sales, representing 74% year-over-year growth. Despite a sequential decline in Truvaga sales, the brand's revenue return on advertising spend was approximately 2.0, with return rates across e-commerce platforms ranging from 10% to 11%. The company's cash balance stood at $7.4 million as of June 30, 2025, and electroCore secured a term debt facility with Avenue Capital, providing approximately $7.2 million in additional net cash. Operating expenses increased to $9.9 million from $7.9 million the previous year, primarily due to investments in sales and marketing. Despite a GAAP net loss of $3.7 million, the company remains focused on long-term growth, planning to increase investments in people, marketing, and product development. ElectroCore anticipates reaching cash-positive status when quarterly revenue reaches between $11.5 million and $12 million, with the potential to achieve this by 2026.

Record Revenue Achievement

ElectroCore posted record revenue of $7.4 million in Q2 2025, marking a 20% year-over-year increase and 10% sequential growth, with strong gross margins at 87%.

Successful Integration of NeuroMetrix

The acquisition of NeuroMetrix was completed ahead of schedule, bringing additional talent and expanding electroCore's product offerings.

VA Hospital System Growth

Revenue from the VA hospital system grew 12% sequentially, with 188 VA facilities now purchasing gammaCore products, up from 175 a year ago.

Truvaga Sales Growth

Truvaga posted $1 million in Q2 sales, a 74% year-over-year increase, and has sold over 16,000 handsets since launch.

Term Debt Facility Secured

ElectroCore secured a term debt facility with Avenue Capital, providing $7.2 million in additional net cash with potential access to another $4.5 million.

Electrocore (ECOR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ECOR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 13, 2025	2025 (Q3)	-0.38 / -	-0.31	―	―	―
Aug 06, 2025	2025 (Q2)	-0.33 / -0.44	-0.38	-15.79% (-0.06)	―
May 07, 2025	2025 (Q1)	-0.48 / -0.47	-0.53	11.32% (+0.06)	―
Mar 12, 2025	2024 (Q4)	-0.30 / -0.37	-0.61	39.34% (+0.24)	―
Nov 13, 2024	2024 (Q3)	-0.33 / -0.31	-0.68	54.41% (+0.37)	―
Aug 07, 2024	2024 (Q2)	-0.43 / -0.38	-1.03	63.11% (+0.65)	―
May 08, 2024	2024 (Q1)	-0.59 / -0.53	-1.24	57.26% (+0.71)	―
Mar 13, 2024	2023 (Q4)	-0.59 / -0.61	-1.22	50.00% (+0.61)	―
Nov 08, 2023	2023 (Q3)	-0.70 / -0.68	-1.2	43.33% (+0.52)	―
Aug 09, 2023	2023 (Q2)	-0.96 / -1.03	-1.2	14.17% (+0.17)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ECOR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$6.93	$4.91	-29.15%
May 07, 2025	$6.81	$5.19	-23.79%
Mar 12, 2025	$13.00	$9.55	-26.54%
Nov 13, 2024	$13.40	$13.60	+1.49%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Electrocore Llc (ECOR) report earnings?

Electrocore Llc (ECOR) is schdueled to report earning on Nov 13, 2025, TBA (Confirmed).

What is Electrocore Llc (ECOR) earnings time?

Electrocore Llc (ECOR) earnings time is at Nov 13, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ECOR EPS forecast?

ECOR EPS forecast for the fiscal quarter 2025 (Q3) is -0.38.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing